Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Monsanto tests DroughtGard maize

Monsanto is to run large-scale trials of hybrids of its new genetically modified DroughtGard drought-tolerant maize line (MON87460) prior to commercial launch in the US in 2013/14. They will involve some 250 farmers on up to 10,000 acres (2,470 ha) across the western Great Plains region. Monsanto will stack the drought-tolerance trait with its Genuity VT Triple Pro, Genuity VT Double Pro and Roundup Ready Corn 2 technologies. The on-farm trials will give farmers a chance to see the performance of these hybrids and to give the company feedback to help it make commercial decisions, notes DroughtGard Hybrids marketing lead Mark Edge. MON87460 was deregulated by the USDA in December last year (Agrow No 631, p 23). The maize expresses a bacterial origin cold shock protein B. It is a product of a collaboration between Monsanto and BASF to develop crops with increased yields and improved tolerance to abiotic stress.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG005874

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel